PRECEDE (Cesarean C-Section Delivery) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out if adding azithromycin to the routine single antibiotic preventative therapy can lower the risk of developing infections after a cesarean delivery.
Cesarean [C-Section] Delivery
Who Can Participate in the Study?
Adults ages 18+ who are pregnant and will be having a scheduled cesarean delivery at Duke University Hospital.
For more information, contact the study team at jennifer.ferrara@duke.edu.
What is Involved?
If you choose to join this study, you will get a random assignment (like a coin flip) to receive either azithromycin or placebo (normal saline) through your existing intravenous (IV) line that is placed before you have your baby. Study participation starts when you come to the hospital to deliver your baby and will end approximately 6 weeks after delivery.
Study Details
